Psilocybin Reduces Symptoms, Disability in Major Depression
Phase 2 data suggest significant sustained benefits with an experimental psilocybin drug in the treatment of major depressive disorder.
Stay updated with breaking news from Tiny Blue Dot Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 2 data suggest significant sustained benefits with an experimental psilocybin drug in the treatment of major depressive disorder.
In the classroom and outside it, neuroscientist David McCormick is leading UO's mindfulness revolution
25 years ago, a neuroscientist and a philosopher made a bet that by now, science and philosophy would understand what makes and defines human consciousness. Want to guess who won?
/PRNewswire/ -- Eleven major neuroscientific research projects related to "The Science of Perception Box" are being funded by the Tiny Blue Dot Foundation,...
/PRNewswire/ -- Up to 10 major neuroscientific research projects related to a concept called "The Science of Perception Box" are being funded by the Tiny Blue...